These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23870416)

  • 1. Translation of viral mRNAs that do not require eIF4E is blocked by the inhibitor 4EGI-1.
    Redondo N; García-Moreno M; Sanz MA; Carrasco L
    Virology; 2013 Sep; 444(1-2):171-80. PubMed ID: 23870416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.
    Papadopoulos E; Jenni S; Kabha E; Takrouri KJ; Yi T; Salvi N; Luna RE; Gavathiotis E; Mahalingam P; Arthanari H; Rodriguez-Mias R; Yefidoff-Freedman R; Aktas BH; Chorev M; Halperin JA; Wagner G
    Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3187-95. PubMed ID: 25049413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-substituted indazoles as configurationally locked 4EGI-1 mimetics and inhibitors of the eIF4E/eIF4G interaction.
    Yefidoff-Freedman R; Chen T; Sahoo R; Chen L; Wagner G; Halperin JA; Aktas BH; Chorev M
    Chembiochem; 2014 Mar; 15(4):595-611. PubMed ID: 24458973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncytotoxic inhibition of viral infection through eIF4F-independent suppression of translation by 4EGi-1.
    McMahon R; Zaborowska I; Walsh D
    J Virol; 2011 Jan; 85(2):853-64. PubMed ID: 21068241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
    De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA
    Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation.
    Avanzino BC; Fuchs G; Fraser CS
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9611-9616. PubMed ID: 28827335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic initiation factor 4G-poly(A) binding protein interaction is required for poly(A) tail-mediated stimulation of picornavirus internal ribosome entry segment-driven translation but not for X-mediated stimulation of hepatitis C virus translation.
    Michel YM; Borman AM; Paulous S; Kean KM
    Mol Cell Biol; 2001 Jul; 21(13):4097-109. PubMed ID: 11390639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia.
    Willimott S; Beck D; Ahearne MJ; Adams VC; Wagner SD
    Clin Cancer Res; 2013 Jun; 19(12):3212-23. PubMed ID: 23633452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
    Ali IK; McKendrick L; Morley SJ; Jackson RJ
    J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
    Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
    Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
    Ohlmann T; Rau M; Pain VM; Morley SJ
    EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
    Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
    Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?
    Burgui I; Yángüez E; Sonenberg N; Nieto A
    J Virol; 2007 Nov; 81(22):12427-38. PubMed ID: 17855553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppression by small molecule inhibitors of translation initiation.
    Chen L; Aktas BH; Wang Y; He X; Sahoo R; Zhang N; Denoyelle S; Kabha E; Yang H; Freedman RY; Supko JG; Chorev M; Wagner G; Halperin JA
    Oncotarget; 2012 Aug; 3(8):869-81. PubMed ID: 22935625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteolytic cleavage of eukaryotic initiation factor (eIF) 4G is prevented by eIF4E binding protein (PHAS-I; 4E-BP1) in the reticulocyte lysate.
    Ohlmann T; Pain VM; Wood W; Rau M; Morley SJ
    EMBO J; 1997 Feb; 16(4):844-55. PubMed ID: 9049313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO-2 promotes mRNA translation by enhancing interaction between eIF4E and eIF4G.
    Chen LZ; Li XY; Huang H; Xing W; Guo W; He J; Sun ZY; Luo AX; Liang HP; Hu J; Wang ZG; Xu YS; Xu X
    PLoS One; 2014; 9(6):e100457. PubMed ID: 24971752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
    Descamps G; Gomez-Bougie P; Tamburini J; Green A; Bouscary D; Maïga S; Moreau P; Le Gouill S; Pellat-Deceunynck C; Amiot M
    Br J Cancer; 2012 May; 106(10):1660-7. PubMed ID: 22510748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.